Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 54,515 | 41,494 | 34,409 | 28,435 | 55,779 |
| Cost of Goods | 6,769 | 1,563 | 421 | 1,362 | 2,447 |
| Gross Profit | 47,746 | 39,931 | 33,988 | 27,073 | 53,332 |
| Operating Expenses | 64,009 | 56,101 | 63,572 | 55,173 | 62,831 |
| Operating Income | -16,263 | -16,170 | -29,584 | -28,100 | -9,499 |
| Interest Expense | 1,400 | 65 | N/A | N/A | N/A |
| Other Income | 4,514 | 4,101 | 3,814 | 2,909 | 1,464 |
| Pre-tax Income | -13,149 | -12,134 | -25,770 | -25,191 | -8,035 |
| Income Tax | 298 | -642 | 436 | 855 | 954 |
| Net Income Continuous | -13,447 | -11,492 | -26,206 | -26,046 | -8,989 |
| Net Income | $-13,447 | $-11,492 | $-26,206 | $-26,046 | $-8,989 |
| EBITDA(a) | $-6,487 | $-11,350 | $-28,867 | $-27,881 | $-8,690 |